Photodynamic therapy with verteporfin in patients with age-related macular degeneration and juxtafoveal choroidal neovascularization

Acta Ophthalmologica Scandinavica

Volumn 82, Issue 6, 2004, Pages 651-655

  Frennesson, Christina I ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Age related macular degeneration; Juxtafoveal choroidal neovascularization; Photodynamic therapy; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; AGED; ARTICLE; BACKACHE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; LASER COAGULATION; MALE; OPTIC DISK; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HEMORRHAGE; STANDARDIZATION; SUBRETINAL NEOVASCULARIZATION; SYMPTOMATOLOGY; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FOVEA CENTRALIS; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 11244349025     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2004.00382.x     Document Type: Article

References (7)

1. Frennesson CI & Nilsson SEG (2004): Encouraging results of photodynamic therapy with Visudyne in a clinical patient material of age-related macular degeneration. Acta Ophthalmol Scand 82.
2. Macular Photocoagulation Study Group (1990): Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized trial. Arch Ophthalmol 108: 816-824.
3. Macular Photocoagulation Study Group (1994): Laser photocoagulation for juxtafaveal choroidal neovascularization. Five-year results from randomized clinical trials. Arch Ophthalmol 112: 500-509.
4. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999): Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of two randomized clinical trials. TAP Report 1. Arch Ophthalmol 117: 1329-1345.
5. Treatment of Age-related Macular Degeneration with Photodynamic Therapy and Verteporfin in Photodynamic Therapy Study Groups (2003): Effect of lesion size, visual acuity and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration. TAP and VIP Report 1. Am J Ophthalmol 136: 407-418.
6. Verteporlin in Photodynamic Therapy (VIP) Study Group (2001): Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization. VIP Report 2. Am J Ophthalmol 131: 541-560.
7. Verteporfin Roundtable 2000 and 2001 Participants & Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Principal Investigators & Verteporfin in Photodynamic Therapy (VIP) Study Group Principal Investigators (2002): Guidelines for using verteporfin (Visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina 22: 6-18.